5NG — Healthway Medical Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- SG$213.17m
- SG$206.51m
- SG$159.89m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.05 | ||
| Price to Tang. Book | 4.77 | ||
| Price to Free Cashflow | 18.94 | ||
| Price to Sales | 1.33 | ||
| EV to EBITDA | 7.77 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.2% | ||
| Return on Equity | 4.35% | ||
| Operating Margin | 7.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 112.67 | 114.25 | 97.43 | 139.92 | 159.89 | n/a | n/a | 8.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +230.56 | +15.97 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Healthway Medical Corporation Limited is a Singapore-based private healthcare provider. The principal activities of the Company are those of an investment holding company and to carry on the business of healthcare management. It offers medical services including general practitioner and family medicine clinics, health screening, adult specialists, and allied healthcare services. Its segments include Primary Healthcare and Specialist Healthcare. Its Primary Healthcare segment consists of family medicine, dentistry, healthcare benefit management and investment in strategic medical-related business. Its Specialist Healthcare segment consists of pediatrics, orthopedics, aesthetic medicine, obstetrics and gynecology, and Nobel specialists consisting of cardiology, gastroenterology, psychiatry, ophthalmology (eye), otorhinolaryngology (ear, nose and throat) and general surgery. Its subsidiaries include Healthway Medical Group Pte Ltd, Unimedic Pte. Ltd., and China Healthway Pte. Ltd.
Directors
- Boon Ann Sin NEC (63)
- Chin Kee Khor CEO (56)
- Abram Suhardiman DCE (31)
- Sheth Sudhirbhai CFO (44)
- Bernard Bernard OTH
- Kelvin Chen OTH
- Kyaw Thein Kyaw OTH
- Alvin Lew OTH
- Chuanjian Chen SEC
- Pei Tsing Chew SEC
- Anand Kumar NED (54)
- Stephen Riady NED (60)
- Aliza Knox IND (60)
- Yeow Sin Chen NID (55)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- May 16th, 2007
- Public Since
- July 4th, 2008
- No. of Shareholders
- 5,004
- No. of Employees
- 454
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 4,535,571,000
- Address
- 6 Shenton Way, #10-09 Oue Downtown, 068809
- Web
- https://www.healthwaymedical.com/
- Phone
- +65 63234415
- Auditors
- Ernst & Young LLP
Upcoming Events for 5NG
Healthway Medical Corporation Ltd Annual Shareholders Meeting
Similar to 5NG
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly JCG
Singapore Exchange Securities Trading Ltd
FAQ
What is the Healthway Medical share price?
As of Today at 18:10 UTC, shares in Healthway Medical are trading at SG$0.05. This share price information is delayed by 15 minutes.
How has the Healthway Medical share price performed this year?
Shares in Healthway Medical last closed at SG$0.05 and the price had moved by +23.68% over the past 365 days. In terms of relative price strength the Healthway Medical share price has outperformed the FTSE Developed Asia Pacific Index by +17.44% over the past year.
What are the analyst and broker recommendations for Healthway Medical?
There is no consensus recommendation for this security.
Find out moreWhat is the Healthway Medical dividend yield?
Healthway Medical does not currently pay a dividend.
Does Healthway Medical pay a dividend?
Healthway Medical does not currently pay a dividend.
When does Healthway Medical next pay dividends?
Healthway Medical does not currently pay a dividend.
How do I buy Healthway Medical shares?
To buy shares in Healthway Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Healthway Medical?
As of the previous close price of SG$0.05, shares in Healthway Medical had a market capitalisation of SG$213.17m.
Where are Healthway Medical shares listed?
Here are the trading details for Healthway Medical:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 5NG
What kind of share is Healthway Medical?
Based on an overall assessment of its quality, value and momentum Healthway Medical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Healthway Medical share price forecast for 2023?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Healthway Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Healthway Medical. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +53.41%.
As of the last closing price of SG$0.05, shares in Healthway Medical were trading +18.43% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Healthway Medical PE Ratio?
The Healthway Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Healthway Medical?
Healthway Medical's management team is headed by:
- Boon Ann Sin - NEC
- Chin Kee Khor - CEO
- Abram Suhardiman - DCE
- Sheth Sudhirbhai - CFO
- Bernard Bernard - OTH
- Kelvin Chen - OTH
- Kyaw Thein Kyaw - OTH
- Alvin Lew - OTH
- Chuanjian Chen - SEC
- Pei Tsing Chew - SEC
- Anand Kumar - NED
- Stephen Riady - NED
- Aliza Knox - IND
- Yeow Sin Chen - NID